Company / Financials
ResMed Financials
FY2011-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableRevenue
$5.1B
FY2025 · +9.8% YoY
Net Income
$1.4B
FY2025 · +37.2% YoY
Profit Margin
27.2%
FY2025 · net income / revenue
ROE
23.5%
FY2025 · return on equity
Total Assets
$8.2B
FY2025
Total Debt
$658.4M
0.11x debt/equity
Equity
$6.0B
FY2025
ROA
17.1%
FY2025 · return on assets
Statement paths
Financial highlights
Key Data Points
- High Piotroski F-Score: 8/9 (strong financial health signals)
- Altman Z-Score 3.25 (safe zone, above 2.9 threshold)
- Strong profit margin: 27.2%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Metric history
Revenue HistoryTotal revenue from operations$5.1B+9.8% YoYNet Income HistoryProfit after all expenses and taxes$1.4B+37.2% YoYGross Profit HistoryRevenue minus cost of goods sold$3.1B+15.1% YoYCost of Revenue HistoryDirect costs of producing goods and services sold$2.1B+3.0% YoYOperating Income HistoryProfit from core business operations before interest and taxes$1.7B+27.7% YoYSG&A Expense HistorySelling, general, and administrative expenses$991.0M+8.1% YoYR&D Expense HistoryResearch and development spending$331.3M+7.7% YoYInterest Expense HistoryCost of borrowing and debt obligations-Income Tax HistoryTotal income tax expense$276.8M+13.5% YoYEPS (Basic) HistoryBasic earnings per share$6.12+14.6% YoY